CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions	Total	Common Stock	Additional Paid-in Capital	Retained Earnings
Beginning balance (in shares) at Dec. 31, 2022		134,715,094
Beginning balance at Dec. 31, 2022	$ 9,124	$ 1	$ 5,724	$ 3,399
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation (in shares)		92,048
Share-based compensation	5		5
Issuance of common stock for warrant exercise (in shares)		4,654
Issuance of common stock for warrant exercise	0
Repurchase and retirement of common stock (in shares)		(792,543)
Repurchase and retirement of common stock	(60)			(60)
Net income (loss)	1,389			1,389
Dividends on common stock	(175)			(175)
Ending balance (in shares) at Mar. 31, 2023		134,019,253
Ending balance at Mar. 31, 2023	10,283	$ 1	5,729	4,553
Beginning balance (in shares) at Dec. 31, 2022		134,715,094
Beginning balance at Dec. 31, 2022	9,124	$ 1	5,724	3,399
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase and retirement of common stock (in shares)		(2,200,000)
Repurchase and retirement of common stock		$ (175)
Net income (loss)	1,780
Ending balance (in shares) at Jun. 30, 2023		132,684,741
Ending balance at Jun. 30, 2023	10,396	$ 1	5,726	4,669
Beginning balance (in shares) at Mar. 31, 2023		134,019,253
Beginning balance at Mar. 31, 2023	10,283	$ 1	5,729	4,553
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation (in shares)		109,012
Share-based compensation	7		7
Issuance of common stock for warrant exercise (in shares)		878
Issuance of common stock for warrant exercise	0
Repurchase and retirement of common stock (in shares)		(1,444,402)
Repurchase and retirement of common stock	(125)		(10)	(115)
Net income (loss)	391			391
Dividends on common stock	(160)			(160)
Ending balance (in shares) at Jun. 30, 2023		132,684,741
Ending balance at Jun. 30, 2023	10,396	$ 1	5,726	4,669
Beginning balance (in shares) at Dec. 31, 2023		130,789,936
Beginning balance at Dec. 31, 2023	10,729	$ 1	5,754	4,974
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation (in shares)		168,538
Share-based compensation	4		4
Issuance of common stock for warrant exercise (in shares)		201
Issuance of common stock for warrant exercise	0
Net income (loss)	26			26
Dividends on common stock	(77)			(77)
Ending balance (in shares) at Mar. 31, 2024		130,958,675
Ending balance at Mar. 31, 2024	10,682	$ 1	5,758	4,923
Beginning balance (in shares) at Dec. 31, 2023		130,789,936
Beginning balance at Dec. 31, 2023	10,729	$ 1	5,754	4,974
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(201)
Ending balance (in shares) at Jun. 30, 2024		131,252,107
Ending balance at Jun. 30, 2024	10,370	$ 1	5,768	4,601
Beginning balance (in shares) at Mar. 31, 2024		130,958,675
Beginning balance at Mar. 31, 2024	10,682	$ 1	5,758	4,923
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation (in shares)		264,072
Share-based compensation	9		9
Issuance of common stock for warrant exercise (in shares)		29,360
Issuance of common stock for warrant exercise	1		1
Net income (loss)	(227)			(227)
Dividends on common stock	(95)			(95)
Ending balance (in shares) at Jun. 30, 2024		131,252,107
Ending balance at Jun. 30, 2024	$ 10,370	$ 1	$ 5,768	$ 4,601